Aurz Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-12-2024
- Paid Up Capital ₹ 2.50 M
as on 16-12-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.56 Cr
as on 16-12-2024
- Revenue -15.99%
(FY 2019)
- Profit -84.82%
(FY 2019)
- Ebitda -55.88%
(FY 2019)
- Net Worth 16.28%
(FY 2019)
- Total Assets -7.60%
(FY 2019)
About Aurz Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹3.56 Cr.
Munjamani Harish, Veeraiah Annadurai, Suresh Bellur, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231KA2007PTC044290
- Company No.
044290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aurz Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munjamani Harish  | Managing Director | 05-Nov-2007 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Veeraiah Annadurai | Director | 07-Jan-2008 | Current |
| Suresh Bellur | Director | 05-Nov-2007 | Current |
| Kavitha Madhusudhan | Director | 25-May-2009 | Current |
| Nagasri Harish | Director | 04-Jul-2022 | Current |
| Vinod Swamy | Director | 06-Jun-2019 | Current |
Financial Performance of Aurz Pharmaceutical.
Aurz Pharmaceutical Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 15.99% decrease. The company also saw a substantial fall in profitability, with a 84.82% decrease in profit. The company's net worth Soared by an impressive increase of 16.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurz Pharmaceutical?
In 2019, Aurz Pharmaceutical had a promoter holding of 95.65% and a public holding of 4.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aurz Nutraceuticals LlpActive 7 years 9 monthsMunjamani Harish and Nagasri Harish are mutual person
- Aurz Lifecare LlpActive 7 years 5 months
Veeraiah Annadurai, Suresh Bellur and 1 more are mutual person
- Axces Remedies Private LimitedActive 6 years 5 months
Veeraiah Annadurai, Suresh Bellur and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 20 Jan 2024 | ₹2.00 M | Open |
Canara Bank Creation Date: 20 Jan 2024 | ₹2.00 M | Open |
Canara Bank Creation Date: 27 Nov 2023 | ₹1.70 M | Open |
How Many Employees Work at Aurz Pharmaceutical?
Aurz Pharmaceutical has a workforce of 20 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurz Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurz Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
